AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Hands hold a smartphone

More than 80% of physicians use AI professionally: AMA survey

| 4 Min Read
People in a group with stacked hands

Embedding physician well-being into system strategy

| 8 Min Read
Smiling woman works at a laptop

Medicare patients get virtual access to diabetes prevention

| 3 Min Read
Operating room corridor

A more accurate Medicare Advantage provider directory on the way

| 4 Min Read